Atika Capital Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-160,000
| Closed | -$5.17M | – | 90 |
|
|
2024
Q1 | $5.17M | Buy |
160,000
+40,000
| +33% | +$1.29M | 0.51% | 61 |
|
|
2023
Q4 | $5.06M | Sell |
120,000
-89,000
| -43% | -$3.75M | 0.68% | 54 |
|
|
2023
Q3 | $8.02M | Buy |
+209,000
| New | +$8.02M | 1.05% | 39 |
|
|
2021
Q1 | – | Sell |
-119,198
| Closed | -$5.51M | – | 95 |
|
|
2020
Q4 | $5.51M | Buy |
119,198
+2,198
| +2% | +$102K | 0.43% | 69 |
|
|
2020
Q3 | $4.12M | Buy |
+117,000
| New | +$4.12M | 0.34% | 68 |
|